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neous interventions.
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BACKGROUND Transradial approach (TrA) has now been established as
the routine method for coronary angiography and percutaneous coronary
intervention (PCI) in many centers around the world. However, many
operators still consider TrA as technically difﬁcult, especially when trying
to access the left internal mammary artery (LIMA) in patients with a
history of coronary artery bypass grafting (CABG). Our aim was to
examine the feasibility and safety of the TrA in this group of patients and
evaluate any potential beneﬁts when performing the procedure through
the Left Radial (LR) versus the Right radial (RR) artery.
METHODS We performed 5,479 transradial catheterizations between
Jan 2006 and Dec 2013. In our center, we established TrA as the
routine method for elective, urgent and emergency procedures (pri-
mary or rescue PCI). Baseline characteristics, procedural success rates
and major complications were recorded.
RESULTS A total of 247 transradial catheterizations were performed on
patients with previous history of CABG involving the LIMA. Among these
catheterizations, the initial approach was through the LR artery (209
cases, 84.6%), the RR artery (33 cases, 13.4%) and the Right Femoral (RF)
artery (5 patients, 2%). The LIMA graft was successfully accessed in all
209 cases performed through the LR artery (100% success rate), in 32 out
of 33 cases performed through the RR artery (97% success rate) and in all
5 RF artery cases (100% success rate). In 1 case, it was not possible to
access the LIMA graft through a RR approach but this was possible after
crossing over to a LR approach. No major complications were noted in
any of the procedures involving access to the LIMA graft.
CONCLUSIONS Our ﬁndings indicate 100% procedural success rate
when attempting access to the LIMA graft through the LR artery as
compared to 97% success rate through the RR artery. Although, both
approaches are associated with a high success rate, we identiﬁed a pref-
erence of our operators to perform such procedures through the LR
(84.6%) instead of the RR artery (13.4%). Our study, provides evidence
regarding the feasibility, efﬁcacy and safety of the TrA in patients with
history of CABG where LIMA was used. Presence of LIMA grafts should
not prevent operators from using transradial access.
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BACKGROUND Anatomic variations affecting radial, brachial and sub-
clavian arteries increase procedural complexity and duration. Preproce-
dural identiﬁcation of these patients may improve procedural metrics.
METHODS Data from the ’Cela Stara Databaza’ were prospectively
collected. Patients undergoing coronary procedures using transradial
access (TRA) were included in the analysis. Radial, brachial and sub-
clavian artery anomalies were systematically studied and radial
angiography was performed on all patients. Patients with radial artery
(RA), brachial artery (BA) or subclavian artery (SA) anomaly were
categorized into “Hostile anatomy” (HA) group. Demographic and
procedural variables were collected on all patients. Univariate ana-
lyses were performed to identify association between collectedvariables and HA. Multivariable analysis was performed using forward
selection to identify independent predictors of HA.
RESULTS 21266 patients undergoing coronary procedures using TRA
were included in the analysis. 68 patients had incomplete data and were
excluded. HA was detected in 1934 (9.1%) patients. HA was signiﬁcantly
more frequent in women compared to men (10.6% vs 8.4%, P ¼ 0.0001),
hypertensive patients (9.9% vs 8%, P ¼ 0.0001), smokers (10.1% vs 8.8%,
P ¼ 0.002), older patients (61 þ 10 vs 62 þ 10, P ¼ 0.004), shorter patients
(169 þ 8 vs 170 þ 8, P ¼ 0.014) and leaner patients (78 þ 12 vs 79 þ 12, P ¼
0.013). Logistic regression analysis using forward selection identiﬁed Age
(O.R 1.1 [1.02-1.1], P ¼ 0.007), Gender (O.R 1.3 [1.1-1.4], P ¼ 0.0001), HTN
(O.R 1.2 [1.1-1.3], P ¼ 0.0001) and Smoking (O.R ¼ 1.2 [1.1-1.4], P ¼ 0.0001)
to be independent predictors of HA. The model had adequate ﬁt (Hosmer-
Lemeshow goodness of ﬁt P ¼ 0.57).
CONCLUSIONS Hostile arterial anatomy can be predicted in patients
presenting for TRA using demographic variables. Preprocedural knowl-
edge of expected complexity may allow the operator to modify equip-
ment choices and procedural approach to lower procedural complexity,
and choose alternative access in time-sensitive circumstances.
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BACKGROUND Recommended iliofemoral diameter for transfemoral
(TF) TAVR with Medtronic CoreValve is >6 mm, but the lowest limit
has not been determined. Our study evaluates the feasibility of TF
TAVR in patients with small iliofemoral access (<5 mm).
METHODS Retrospective analysis of the STS/ACC Transcatheter Valve
Therapy (TVT) Registry at 2 institutionswas performed on 227 consecutive
patients who underwent TAVR from 1/2014 to 5/2015. 44 patients under-
went TAVRwithMedtronic CoreValve using the 11/19-French recollapsible
TerumoSolopath sheath,which has a 4.45mmouter diameter (OD) arterial
entry expanding to 7.67 mm OD, then recollapses to approximately
4.45 mm at sheath removal. Valve sizing and vascular access were deter-
mined by computed tomography. Outcomes were determined using Valve
Academic Research Consortium 2 (VARC-2) deﬁnitions.
RESULTS Eight of 44 Solopath patients had minimal luminal diameter
(MLD) of iliofemoral artery <5.0 mm (mean 4.3þ/-0.7 mm, range 3.1-
5.0 mm), with eccentricity ratio (maximum/minimum diameter-1) at MLD
ranging 2-67%. Vessel calciﬁcation ranged <90 to 360 and tortuosity
ranged <45 to >90. At the MLD, sheath-to-artery (SAR) ratios, based on
the fully expanded 7.67 mm OD, ranged 1.53-2.47, higher than previously
reported ratios that risk vascular complications. Major comorbidities
included severe COPD on home oxygen, extreme thrombocytopenia,
cirrhosis, prior malignancy, prior cardiac surgery, poor ventricular func-
tion, diabetesmellitus, chronic renal failure, frailty.All, deemedunsuitable
for TAVR using alternative access, had TF TAVRwith IV sedation and local
anesthesia, with 100% success, 0% vascular complications, and 0%
bleeding in-hospital and at 30 days (Table 1).
CONCLUSIONS TF TAVR using the 11/19-French recollapsible Terumo
Solopath sheath is safe in selected small iliofemoral access, even in
diameter <5 mm without any complications. A more aggressive TF
approach may be considered in select patients who are frail and high
risk for alternative access.
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BACKGROUND Patients with congestive heart failure (CHF) requiring
invasive coronary diagnostics or intervention are at high ischemic as
well as hemorrhagic risk. Therefore, Therefore, the radial approach in
this subset of patients seems to be an appealing strategy.
METHODS This is a prospective, web-based all-comers registry of
patients with CHF who underwent CAG or PCI between 2013 and 2014
via radial (RA) or femoral approach (FA), according to cardiac revas-
cularization guidelines. We evaluated the incidence of a composite
endpoint of bleeding and major vascular adverse events (NET) as well
mortality at 30-day follow-up. Propensity score was used for baseline
characteristics matching and results adjustment.
RESULTS In total 1357 patients were enrolled. The radial approach
was utilized in 277, whereas femoral in 1081 patients. At baseline,
patients in the radial approach arm were slightly younger (64,0  10
vs. 65,9  10 y.o. ; p<0,01), had higher ejection fraction (36,5  14 vs.
33.1 17%; p¼0,04) and less often presented STEMI (6,1% vs.
2,9%;p¼0,05) or NSTEMI (2,9% vs. 8%;p<0,01). On the other hand RA
patients more often presented with atrial ﬁbrillation requiring oral
anticoagulant therapy (42,2% vs. 23%; p<0,01). There was nodifference in the ﬂuroscopy time (11,8 vs. 9,7 min, p¼0,22) as well
contrast volume (125 vs. 150 ml; p¼0,43) between RA and FA, how-
ever the total radiation dose was lower in the FA (0,71 vs. 0,83 Gy;
p¼0,01). At 30 days, the occurrence of NET adverse events (0,36% vs.
2,8%; p¼0,04) transfusion (0% vs. 1,6%; p¼0,04) and death (1,1% vs.
3,2%;p¼0,05) was in favor of RA. After adjustment for baseline
characteristics 277 well-matched pairs were chosen. The occurrence
of major bleeding and vascular events remained in favor of RA (0 vs.
3,2%; p¼0,05. OR: 0.05; 95%CI: 0,1-0,8), whereas the mortality dif-
ference also tended to favor RA (1,0 vs. 2,9%; p¼0,12 OR: 2.7; 95%CI:
0,7-10).
CONCLUSIONS Conclusion. In this registry, radial approach in pa-
tients with CHF undergoing coronary invasive procedures reduced the
incidence of major bleeding events and major vascular complications.
Therefore, we generate the hypothesis that the radial approach should
be considered as primary approach in this subgroup of patients.
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BACKGROUND The feasibility and safety of robotic PCI via trans-
femoral (TFA) access has been demonstrated. However, there is
limited data for robotic PCI via transradial access (TRA). The goal of
this study is to compare clinical and technical outcomes for radial
versus femoral access robotic PCI.
METHODS The multicenter PRECISION post-market registry of robotic
PCI collected clinical and procedural data of robotic PCI procedures
utilizing the CorPath System (Corindus Vascular Robotics, Inc., Wal-
tham, MA) in 9 sites. Technical success was deﬁned as lesions suc-
cessfully treated with robotic PCI and residual stenosis <30%. Clinical
success was deﬁned as <30% residual stenosis and absence of major
adverse cardiovascular events (MACE, which was deﬁned as cardiac
death, myocardial infarction, or clinically driven target vessel revas-
cularization) at hospital discharge or 72 hours post-procedure,
whichever came ﬁrst.
RESULTS Of 273 patients and 334 lesions (at 9 sites) TRA robotic PCI was
done in 156 (57%) and TFA robotic PCI in 117 (43%). The two groups were
comparable except for the TFA access group having a greater proportion
of diabetics and type C lesions (Table 1). TRA and TFA robotic PCI
technical success rates were 93.7% and 85.7%, respectively (P¼0.02)
and clinical success rates were 99.4% and 97.4% respectively (P¼0.32).
Three serious adverse events (SAE) unrelated to the CorPath System
occurred during the study period. Of these 3 SAEs, none were
determined MACE as deﬁned by the protocol.
